Ghent University Academic Bibliography

Show Sort by

Your filters: cql: parent exact "HEPATOLOGY"

Mark
Placental growth factor inhibition targets pulmonary angiogenesis and represents a novel therapy for hepatopulmonary syndrome in mice

Sarah Raevens (UGent) , Anja Geerts (UGent) , Annelies Paridaens (UGent) , Sander Lefere (UGent) , Xavier Verhelst (UGent) , Anne Hoorens (UGent) , Jo Van Dorpe (UGent) , Tania Maes (UGent) , Ken Bracke (UGent) , Christophe Casteleyn (UGent) , et al.

(2018) HEPATOLOGY. 68(2). p.634-651
Mark
Angiopoietin-2 promotes pathological angiogenesis and is a novel therapeutic target in murine non-alcoholic fatty liver disease

Sander Lefere (UGent) , Frederique Van de Velde (UGent) , Anne Hoorens (UGent) , Sarah Raevens (UGent) , Sanne Van Campenhout (UGent) , Astrid Vandierendonck (UGent) , Sara Neyt (UGent) , Bert Vandeghinste (UGent) , Christian Vanhove (UGent) , Charlotte Debbaut (UGent) , et al.

(2018) HEPATOLOGY.
Mark
- misc
Refractory subacute steatohepatitis after biliopancreatic diversion

Sander Lefere (UGent) , Anne Hoorens (UGent) , Sarah Raevens (UGent) , Roberto Troisi (UGent) , Xavier Verhelst (UGent) , Hans Van Vlierberghe (UGent) and Anja Geerts (UGent)

(2017) HEPATOLOGY. 66(1). p.289-291
Mark
- conference
- C3
Time trends in major hepatic complications in primary biliary cholangitis : incidence and transplant-free survival

Maren H Harms, Willem J Lammers, Douglas Thorburn, Christophe Corpechot, Pietro Invernizzi, Harry L Janssen, Pier Maria Battezzati, Frederik Nevens, Keith D Lindor, Annarosa Floreani, et al.

(2017) HEPATOLOGY. 66(suppl. 1). p.40A-40A
Mark
- conference
- C3
Recurrence of primary biliary cholangitis after liver transplantation affects graft survival : a multi-center study from the Global PBC study group

Aldo J Montano-Loza, Bettina E Hansen, Davide Roccarina, Douglas Thorburn, Palak J Trivedi, Gideon Hirschfield, Christophe Corpechot, Raoul Poupon, Jerome Dumortier, Alexie Bosch, et al.

(2017) HEPATOLOGY. 66(suppl. 1). p.163A-164A
Mark
- conference
- C3
Time-dependent factors associated with diminished transplant-free survival in patients with primary biliary cholangitis and an optimal response to ursodeoxycholic acid after one year of treatment

Willem J Lammers, Jorn C Goet, Marlyn J Mayo, Ann-Arosa Floreani, Pietro Invernizzi, Maren H Harms, Christophe Corpechot, Keith D Lindor, Cyriel Y Ponsioen, Harry L Janssen, et al.

(2017) HEPATOLOGY. 66(suppl. 1). p.157A-158A
Mark
- conference
- C3
Bilirubin is predictive of transplant-free survival even within the normal range in primary biliary cholangitis patients

Carla F. Murillo Perez, Aliya Gulamhusein, Henk R. van Buuren, Willem J. Lammers, Jorn C. Goet, Cyriel Y. Ponsioen, Marco Carbone, Andrew Mason, Christophe Corpechot, Marlyn J. Mayo, et al.

(2017) HEPATOLOGY. 66(suppl. 1). p.41A-42A
Mark
- conference
- C3
Moving from early to moderate or advanced biochemical disease stage during follow-up is associated with an increasing risk of clinical events in primary biliary cholangitis patients

Nikolaos K Gatselis, Jorn C Goet, Kalliopi Zachou, Willem J Lammers, Harry L Janssen, Gideon Hirschfield, Christophe Corpechot, Keith D Lindor, Pietro Invernizzi, Marlyn J Mayo, et al.

(2017) HEPATOLOGY. 66(suppl. 1). p.169A-170A
Mark
- conference
- C3
Association between ursodeoxycholic acid therapy and prolonged transplant-free survival among patients with primary biliary cholangitis a number needed to treat analysis

Maren H Harms, Annarosa Floreani, Douglas Thorburn, George N Dalekos, Harry L Janssen, Christophe Corpechot, Pietro Invernizzi, Marlyn J Mayo, Pier Maria Battezzati, Henk R van Buuren, et al.

(2016) HEPATOLOGY. 64(suppl. 1). p.188A-188A
Mark
- conference
- C3
Placental growth factor inhibition alleviates hepatopulmonary syndrome in mice

Sarah Raevens (UGent) , Annelies Paridaens (UGent) , Sander Lefere (UGent) , Bart Jonckx, Xavier Verhelst (UGent) , Hans Van Vlierberghe (UGent) , Christophe Van Steenkiste (UGent) , Anja Geerts (UGent) , Lindsey Devisscher (UGent) and Isabelle Colle (UGent)

(2016) HEPATOLOGY. 64(suppl. 1). p.82A-82A

Academic Bibliography

Placental growth factor inhibition targets pulmonary angiogenesis and represents a novel therapy for hepatopulmonary syndrome in mice

Angiopoietin-2 promotes pathological angiogenesis and is a novel therapeutic target in murine non-alcoholic fatty liver disease

Refractory subacute steatohepatitis after biliopancreatic diversion

Time trends in major hepatic complications in primary biliary cholangitis : incidence and transplant-free survival

Recurrence of primary biliary cholangitis after liver transplantation affects graft survival : a multi-center study from the Global PBC study group

Time-dependent factors associated with diminished transplant-free survival in patients with primary biliary cholangitis and an optimal response to ursodeoxycholic acid after one year of treatment

Bilirubin is predictive of transplant-free survival even within the normal range in primary biliary cholangitis patients

Moving from early to moderate or advanced biochemical disease stage during follow-up is associated with an increasing risk of clinical events in primary biliary cholangitis patients

Association between ursodeoxycholic acid therapy and prolonged transplant-free survival among patients with primary biliary cholangitis a number needed to treat analysis

Placental growth factor inhibition alleviates hepatopulmonary syndrome in mice

Contents

Support

Contact